International Journal of Immunopathology and Pharmacology · 2006 · 27 citations · 5 references
MedicineDermatologyPharmacotherapyDermatopathologyImmunopathologyImmunotherapyGranulomatous DermatosesGranulomatous InflammationImmunopathology Of SkinCyclosporine DosingDose TaperingDrug-related Side EffectsGranuloma ResolutionGranulomatous EruptionsGranulomatous LesionsGranulomatous Skin InflammationTreatment-related Side Effects
Granuloma annulare is an anatomo-clinical entity that is frequently encountered in everyday dermatological practice. We report our experience regarding 4 patients with disseminated granuloma annulare. Each patient was treated with a cycle of cyclosporine therapy for six weeks. A cycle of systemic cyclosporine therapy was started at a dose of 4 mg/kg/day for four weeks, subsequently reduced by 0.5 mg/kg/day every two weeks. The clinical picture more or less completely resolved within three weeks in all of the patients, and there were no relapses during the dose-tapering period or the following 12 months. Cyclosporine was optimally tolerated by all four patients, none of whom experienced any therapy-related side effects. Cyclosporine is a valid therapeutic option for the treatment of disseminated granuloma annulare, although we recommend its use in a protected hospital environment that facilitates patient monitoring.
5
Differential Diagnosis in Dermatopathology
A. Bernard Ackerman · JAMA · 1983 · 35 citations
Medicine, Dermatology, Pathology +10
Skin Granuloma Formation in Mice Immunosuppressed by Cyclosporine
Hideko Suya, Akira Fujioka, Carlo Pincelli et al. · Journal of Investigative Dermatology · 1988 · 13 citations · Full text
Medicine, Immunology, Pathology +12
T-cell independent transfer of organized granuloma formation
W. L. Epstein, Masahiro Okamoto, Hideko Suya et al. · Immunology Letters · 1986 · 12 citations
Life Sciences, Immunology, Pathology +14